https://repertaxininhibitor.co....m/murine-kinds-of-my
No discernible impact on clinical outcomes was evident after MHRT for low-risk PC, as a result of the employed RT technique. In patients treated with MHRT using IMRT or 3D-CRT, although late genitourinary (GU) toxicity distributions varied, no differences were noted in late-stage Grade 2 or higher GU or gastrointestinal (GI) toxicity, or in the patient-reported outcomes. Increases in late genitourinary and gastrointestinal toxicity observed after MHRT compared to CFRT in the initial RTOG 0415 publication, do not appear to s
Respect!
Kommentar
Delen
